EGFR and cancer: Extensive research has led to the characterization of the structure and signaling of EGFR, identification of its mutations [5] and gene amplification, definition of its role in cancer development [6], and consequently, the development of tyrosine kinase inhibitors as anti-cancer therapies [7].